top of page
Behavioral aspects and neurobiological properties underlying medical cannabis treatment in Shank3 mouse model of autism spectrum disorder. Shani Poleg et al. Translational Psychiatry volume 11, Article number: 524 (2021)
New insight into how cannabidiol takes effect in the brains of people with psychosis
KGL, January 20, 2020
Cognitive functioning following long-term cannabidiol use in adults with treatment-resistant epilepsy
Epilepsy Behav. 2019 Aug;97:105-110.
Oral Cannabidiol Use in Children With Autism Spectrum Disorder to Treat Related Symptoms and Co-morbidities
Front. Pharmacol., 09 January 2019
Real life Experience of Medical Cannabis Treatment in Autism: Analysis of Safety and Efficacy
Scientific Reports volume 9, article number: 200 (2019)
Plasma anandamide concentrations are lower in children with autism spectrum disorder
Karhson et al. Molecular Autism (2018) 9:18
Cannabinoids in Pediatrics
The Journal of Pediatric Pharmacology and Therapeutics, 2017 May-Jun; 22(3): 176–185
Endocannabinod Signal Dysregulation in Autism Spectrum Disorders: A Correlation Link between Inflammatory State and Neuro-Immune Alterations
International Journal of Molecular Sciences, 3 July 2017
Evidence for a Common Endocannabinoid-Related Pathomechanism in Autism Spectrum Disorders
Neuron, Volume 78, Issue 3, 8 May 2013, Pages 408-410
bottom of page